Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the
third most common cause of cancer-related deaths; the number of new cases per year is …

BACKGROUND & AIMS: The aim of this study was to generate an improved prognostic
model for predicting recurrence in liver transplant candidates with hepatocellular carcinoma …

Objective: The aim of this study was to evaluate the survival benefit of sirolimus in patients
undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC)(exploratory …

Hepatocellular carcinoma (HCC) is a highly prevalent, treatment-resistant malignancy with a
multifaceted molecular pathogenesis. Current evidence indicates that during …

Background We investigated whether sirolimus-based immunosuppression improves
outcomes in liver transplantation (LTx) candidates with hepatocellular carcinoma (HCC) …

Objective: To review the literature on current management of hepatocellular carcinoma
(HCC). Background: Hepatocellular carcinoma represents one of the most common …

Background & Aims The AFP model was shown to be superior to the Milan criteria for
predicting hepatocellular carcinoma (HCC) recurrence after liver transplantation in a French …

We previously suggested that in patients with heptocellular carcinoma (HCC), the
conventional Milan criteria (T1/T2) for orthotopic liver transplantation (OLT) could be …

As newer immunosuppressive regimens have steadily reduced the incidence of acute
rejection and have extended the life expectancy of allograft recipients, posttransplant …